Cytosorbents CorporationCTSONASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$25.13M
↑ 50% above average
Average (9y)
$16.74M
Historical baseline
Range
High:$29.06M
Low:$1.84M
CAGR
+33.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $25.13M | +14.5% |
| 2023 | $21.95M | +5.9% |
| 2022 | $20.73M | -28.7% |
| 2021 | $29.06M | +2.3% |
| 2020 | $28.40M | +84.4% |
| 2019 | $15.40M | +20.7% |
| 2018 | $12.76M | +62.3% |
| 2017 | $7.86M | +84.9% |
| 2016 | $4.25M | +130.7% |
| 2015 | $1.84M | - |